Colon Adenocarcinoma — Trials

Colon Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

132 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 15
Ph III recruiting: 2
Growth YoY: —
Industry share: 11%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 34.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04044430	Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer	terminated	Phase 1	2	University of California, San FranciscoOTHER	1	Jan 9, 2023	clinicaltrials
NCT01285102	Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer	terminated	Phase 1	4	Fox Chase Cancer CenterOTHER	1	Dec 20, 2021	clinicaltrials